efficacy

You have access
Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma
KYOSUKE NISHIO, KENSUKE HIROSUNA, TAIZO UCHIMOTO, HEIMA NIIGAWA, SHO KAKUMAE, TAISUKE JO, HIROFUMI MORINAKA, WATARU FUKUOKAYA, ATSUHIKO YOSHIZAWA, MASANOBU SARUTA, MAMORU HASHIMOTO, TAKAFUMI MINAMI, YUTAKA YAMAMOTO, MORITOSHI SAKAMOTO, KAZUKI NISHIMURA, RYOICHI MAENOSONO, TAKUYA TSUJINO, YUKI YOSHIKAWA, FUMIHIKO URABE, KEIICHIRO MORI, TAKAFUMI YANAGISAWA, SHUNSUKE TSUDUKI, KIYOSHI TAKAHARA, TERUO INAMOTO, KAZUTOSHI FUJITA, TAKAHIRO KIMURA, HARUHITO AZUMA and KAZUMASA KOMURA

Anticancer Research October 2025, 45 (10) 4575-4583; DOI: https://doi.org/10.21873/anticanres.17803
You have access
Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety
TAKAE OKUNO, MASAFUMI HONGOH, RYOSUKE TANINO, TAMIO OKIMOTO, YUKARI TSUBATA and TAKESHI ISOBE

Anticancer Research June 2025, 45 (6) 2551-2561; DOI: https://doi.org/10.21873/anticanres.17627
Open Access
Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue Sarcoma
SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

Anticancer Research September 2024, 44 (9) 3777-3783; DOI: https://doi.org/10.21873/anticanres.17202
You have access
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study
JWA HOON KIM, YONGJUN CHA, SANG JOON SHIN, YOUNG SUK PARK, JUNG HUN KANG, CHAN KIM, SUNG HEE LIM, MYOUNG JOO KANG, JONG GWANG KIM, IN GYU HWANG, JONG-KWON CHOI, SEONG HOON SHIN, SEOK YUN KANG, SANG-CHEOL LEE, SEUNG TAEK LIM, JUNG SUN KIM, HEI-CHEUL JEUNG, MYOUNG HEE KANG, IN SIL CHOI, HYE WON RYU, KYUNG HEE LEE, MOON HEE LEE, JI YOUNG LEE, JI HYUN PARK, SO-YEON JEON, NAMSU LEE, CHI-YOUNG PARK and YEUL HONG KIM

Anticancer Research January 2024, 44 (1) 347-359; DOI: https://doi.org/10.21873/anticanres.16818
You have access
Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study
SUNG HEE LIM, JUNG YONG HONG, JOON OH PARK, YOUNG SUK PARK and SEUNG TAE KIM

Anticancer Research September 2023, 43 (9) 4161-4167; DOI: https://doi.org/10.21873/anticanres.16607
Open Access
Real-world Efficacy and Safety of Bevacizumab for Advanced or Recurrent Müllerian Cancer: A Single-institutional Experience
TAKESHI FUKUDA, TAKUYA NODA, EIJIRO UCHIKURA, YUICHIRO AWAZU, REIKO TASAKA, KENJI IMAI, MAKOTO YAMAUCHI, TOMOYUKI ICHIMURA, TOMOYO YASUI and TOSHIYUKI SUMI

Anticancer Research July 2023, 43 (7) 3097-3105; DOI: https://doi.org/10.21873/anticanres.16481
You have access
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients
HELENA LINARDOU, SOFIA LAMPAKI, GEORGIA-ANGELIKI KOLIOU, ATHANASSIOS VOZIKIS, ANASTASIOS BOUTIS, ADAMANTIA NIKOLAIDI, IOANNIS KONTOGIORGOS, PAVLOS PAPAKOTOULAS, ATHINA CHRISTOPOULOU, DIONYSIOS SPYRATOS, DIMITRIOS BAFALOUKOS, AMANDA PSYRRI, ANASTASIOS GRIVAS, ANNA KOUMARIANOU, KARYOFYLLIS TSIAKITZIS, DAVIDE MAURI, GEORGIOS RIGAKOS, GERASIMOS ARAVANTINOS, PANAGIOTIS PAPANTONIOU, GEORGIOS OIKONOMOPOULOS, ELENA FOUNTZILAS, MARGARITA-IOANNA KOUFAKI, MARIA KAPARELOU, ELIAS LIOLIS, GIANNIS MOUNTZIOS, PARIS KOSMIDIS, GEORGE FOUNTZILAS and EPAMINONDAS SAMANTAS

Anticancer Research June 2023, 43 (6) 2799-2812; DOI: https://doi.org/10.21873/anticanres.16449
Open Access
Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model
NORIYUKI MASAKI, QINGHONG HAN, CARISSA SAMONTE, NATHANIEL F. WU, CHIHIRO HOZUMI, JUSTIN WU, KOYA OBARA, YUTARO KUBOTA, YUSUKE AOKI, MICHAEL BOUVET and ROBERT M. HOFFMAN

Anticancer Research November 2022, 42 (11) 5217-5222; DOI: https://doi.org/10.21873/anticanres.16028
You have access
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research February 2022, 42 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.15531
You have access
The Combination of Cisplatinum and Doxorubicin Regressed Primary Osteosarcoma of the Breast in a PDOX Mouse Model
NATHANIEL F. WU, JUN YAMAMOTO, YUSUKE AOKI, NORIYUKI MASAKI, CARISSA SAMONTE, JUSTIN WU, MICHAEL BOUVET and ROBERT M. HOFFMAN

Anticancer Research October 2021, 41 (10) 4715-4718; DOI: https://doi.org/10.21873/anticanres.15285

Main menu

User menu

Search

efficacy

Pages